 "Bavarian Nordic faces pressure to lower mpox vaccine prices as African nations struggle to afford costly shots amidst rising outbreaks.")
Bavarian Nordic faces pressure to lower mpox vaccine prices as African nations struggle to afford costly shots amidst rising outbreaks.
Bavarian Nordic A/S’s mpox vaccine pricing is becoming a major hurdle in securing millions of doses for African nations facing health crises. With the price set at around $100 to $141 per dose, it far exceeds what many African countries can afford, especially given ongoing health challenges like cholera and malaria. As UNICEF and other ...
